Skip to content
GLP-1 Scorecard
Menu

Head-to-head · WeighScore

PlexusDx vs The Virtual NP

PlexusDx
Graded #158

Higher grade

vs+6.900000000000006
The Virtual NP
Graded #314

Lower grade

The verdict

PlexusDx takes it — 67.7/100 to 60.8/100.

PlexusDx grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. PlexusDx (plexusdx.com) is a US GLP-1 telehealth platform offering compounded weight-loss medications with licensed providers in all 50 states.

We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.

Factor by factor

The same six graded dimensions, side by side. See the methodology.

Cost valuePlexusDx +29
74
45
Dose & formulationPlexusDx +11
64
53
Clinical oversightThe Virtual NP +20
74
94
Labs & monitoringThe Virtual NP +2
52
54
FulfillmentPlexusDx +14
78
64
Contract termsEven
55
55
PlexusDx · left barThe Virtual NP · right bar

The numbers

MetricPlexusDxThe Virtual NP
WeighScore67.7/10060.8/100
GradeCC
Scorecard rank#158#314
Semaglutide$149/mo (starting dose, compounded)Not disclosed
Tirzepatide$249/mo (starting dose, compounded)Not disclosed
CoverageAll 50 states7 states
Brand-name accessCompounded onlyYes
Oral / sublingualInjection onlyInjection only
PlexusDx

Graded #158 · C

Strengths

  • Licensed providers available in all 50 states
  • Range of options including low-cost microdose GLP-1 from $129/mo
  • Optional Precision Peptide genetic panel adds a personalization angle
  • Independent clinician review via state-licensed telehealth platform
  • Compounded medications from state-licensed pharmacies

Where it loses points

  • Compounded medications only; no FDA-approved brand options
  • Specific compounding pharmacies not named
  • Genetic-panel upsell may not add clinical value for everyone
  • Tirzepatide pricing from $249/mo is higher than budget rivals
  • No insurance accepted
The Virtual NP

Graded #314 · C

Strengths

  • FDA-approved branded Zepbound and Wegovy only, no compounded
  • Transparent fees: 99 visit or 75 per month membership
  • HSA/FSA accepted and prior authorization assistance offered
  • NP-led with same or next-day booking and home shipping

Where it loses points

  • Branded only, so medication cost is high and billed separately
  • Limited to seven states
  • No compounded lower-cost GLP-1 alternative
  • Single-provider practice may limit scale and hours

Also worth a look

Neither is our top-graded pick — CoreAge Rx leads the scorecard

Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.

Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.

← Back to the scorecard